Richard Friedman: Difference between revisions
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 8: | Line 8: | ||
|twitter = | |twitter = | ||
|facebook = | |facebook = | ||
|linkedin = http://www.linkedin.com/pub/richard-friedman/3/839/1ab | |linkedin = http://www.linkedin.com/pub/richard-friedman/3/839/1ab | ||
|userbox = | |userbox = | ||
}} | }} | ||
| Line 20: | Line 20: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist}} | ||
[[Category: | |||
[[Category:IPC]] | |||
[[Category:Lawyers]] | |||
Latest revision as of 19:33, 20 December 2021
 |
 |
| Country: | USA |
| Email: | richard.friedman [at] pfizer.com |
| LinkedIn: |  Richard Friedman
|
Richard Friedman has been an Assistant General Counsel at Pfizer since November 2010, though he has been with the company since December 2000. Pfizer is a multinational pharmaceutical and consumer healthcare company, where Mr. Friedman works to protect the company's non-patent IP assets including trademarks, trade dress, copyrights, and domain names.[1][2] He has over two decades of experience in law.[1]
He is involved with ICANN through the new gTLDs Subcommittee and the INTA Internet Committee.[2]
ICANN 51 in Los Angeles was Mr. Friedman's first ICANN Meeting.[2]